We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Swiss Regulator Absolved of ‘Generic’ Approvals, Will Focus on ‘Known APIs’
Swiss Regulator Absolved of ‘Generic’ Approvals, Will Focus on ‘Known APIs’
November 6, 2013
Beginning in 2014, Switzerland’s therapeutic product regulator will no longer be approving “generics,” and will instead only be authorizing known active pharmaceutical ingredients (API).